| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/21/2002 | US20020022627 Inhibition of cyclooxygenase-2activity |
| 02/21/2002 | US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging |
| 02/21/2002 | US20020022620 Reverse-turn mimetics and methods relating thereto |
| 02/21/2002 | US20020022619 Administering to the mammal suffering from anxiety, depression and other disorders related to excessive corticotropin releasing factor an effective amount of tricyclic pyridine or pyrimidine derivatives |
| 02/21/2002 | US20020022615 Cyclic oxyguanidine protease inhibitors |
| 02/21/2002 | US20020022610 Compositions and methods for treating bacterial infections |
| 02/21/2002 | US20020022595 Treating inflammation resulting from a response of the non-specific defense system in a mammal by administering an antiinflammatory agent and the uncontaminated Mac-1 alpha subunit |
| 02/21/2002 | US20020022236 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 02/21/2002 | US20020022218 Methods for the identification of compounds useful for the treatment of disease states medicated by prostaglandin D2 |
| 02/21/2002 | DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands |
| 02/21/2002 | DE10039199A1 Kombinationspräparate aus einem ERß selektiven Estrogen und einem SERM oder Antiestrogen Combination preparations of ERß a selective estrogen and a SERM or antiestrogen |
| 02/21/2002 | DE10038639A1 New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism |
| 02/21/2002 | CA2685447A1 Pharmaceutical composition |
| 02/21/2002 | CA2419985A1 Modulating multiple lineage kinase proteins |
| 02/21/2002 | CA2419855A1 Stimulating neutrophil function to treat inflammatory bowel disease |
| 02/21/2002 | CA2419790A1 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | CA2419550A1 Substituted pyrazoles |
| 02/21/2002 | CA2419540A1 Substituted pyrazoles |
| 02/21/2002 | CA2419491A1 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | CA2419073A1 Novel alicyclic imidazoles as h3 agents |
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | CA2418725A1 Claudin polypeptides |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2416794A1 Method and composition for altering a t cell mediated pathology |
| 02/21/2002 | CA2415353A1 Use of antibodies against specific mhc-peptide complexes |
| 02/21/2002 | CA2387002A1 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/20/2002 | EP1180518A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 02/20/2002 | EP1180369A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY |
| 02/20/2002 | EP1180239A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 02/20/2002 | EP1180159A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 02/20/2002 | EP1180146A1 Secreted alpha-helical protein - 32 |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
| 02/20/2002 | EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | EP1180100A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/20/2002 | EP1180053A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180026A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 02/20/2002 | EP1180017A1 Preparation for the application of anti-infective and/or anti-inflammatory agents |
| 02/20/2002 | EP1041896B1 Fat blend |
| 02/20/2002 | EP0917463B1 Tramadol multiple unit formulations |
| 02/20/2002 | EP0841922B1 1h-4(5)-substituted imidazole derivatives |
| 02/20/2002 | EP0772441B1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 02/20/2002 | EP0730447B1 Fatty acid delivery system |
| 02/20/2002 | CN1336932A Macrolides with anti-inflammatory activity |
| 02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336821A Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their prepn. and therapeutic use |
| 02/20/2002 | CN1336819A Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 02/20/2002 | CN1336817A Topical composition comprising N-acetylaldosamines or N-acetylamino acids |
| 02/20/2002 | CN1336552A Method for detecting failure welding of IC terminal by using resonating type sensor coil |
| 02/20/2002 | CN1336367A Mercaptoone and mercaptol, and prepn. process therefor |
| 02/20/2002 | CN1336227A Traditional Chinese medicine for treating rheumatic heart disease |
| 02/20/2002 | CN1336215A Medicine for treating rheumatism and cold pain and its utilizing method |
| 02/20/2002 | CN1079390C Propynyl or dienyl diaromatic compounds |
| 02/20/2002 | CN1079263C Caspule for curing chronic enteritis |
| 02/20/2002 | CN1079255C Medical wine for treating rheumatism |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
| 02/19/2002 | US6348497 Prosthetic joints by reducing bone degradation |
| 02/19/2002 | US6348487 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/19/2002 | US6348472 NPY antagonists: spiroisoquinolinone derivatives |
| 02/19/2002 | US6348468 Pyridazine compounds and compositions containing the same |
| 02/19/2002 | US6348466 CRF receptor antagonists and methods relating thereto |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | CA2204604C Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012495A1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012448A1 Methods for culturing human lung mast cells and uses thereof |
| 02/14/2002 | WO2002012346A2 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | WO2002012345A2 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012275A2 Lat peptides and their use in assays for identifying immunosuppressants |
| 02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
| 02/14/2002 | WO2002012258A1 New immunoeffector compounds |
| 02/14/2002 | WO2002012250A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 02/14/2002 | WO2002012249A2 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012243A2 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012238A2 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012228A1 Cinnoline compounds |
| 02/14/2002 | WO2002012227A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012226A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |